Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors

• Autores principales: Francesca Barei (Autor), Paolo Calzari (Autor), Luca Valtellini (Autor), Alessandra Chiei Gallo (Autor), Gabriele Perego (Autor), Simona Tavecchio (Autor), Martina Zussino (Autor), Angelo V. Marzano (Autor), Silvia Ferrucci (Autor)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background Atopic dermatitis (AD) profoundly impacts patients' lives, necessitating long-term systemic treatments.Methods This retrospective study involved 709 severe AD patients receiving dupilumab. Drug survival (DS) was analyzed using Kaplan-Meier curves, evaluating reasons for discontinuati...